Aesthet Surg J:自体脂肪移植进行丰胸美容可靠吗?

2019-01-12 MedSci MedSci原创

自体脂肪移植(AFG)越来越多地用于整容手术。然而,其功效和安全性仍有争议。许多研究探究了AFG在乳房美容手术中的功效。本综述提供了有关AFG在美容丰胸中的文献的最新概述。根据用于系统评价和Meta分析的优选报告项目(PRISMA)指南,对用于美容丰胸的AFG的相关文献进行系统评价。该研究纳入了1996年1月至2016年2月期间发表的选定研究,并报告了10名患者,其平均随访期为1年。结果,研究纳入

自体脂肪移植(AFG)越来越多地用于整容手术。然而,其功效和安全性仍有争议。许多研究探究了AFG在乳房美容手术中的功效。本综述提供了有关AFG在美容丰胸中的文献的最新概述。

根据用于系统评价和Meta分析的优选报告项目(PRISMA)指南,对用于美容丰胸的AFG的相关文献进行系统评价。该研究纳入了1996年1月至2016年2月期间发表的选定研究,并报告了10名患者,其平均随访期为1年。

结果,研究纳入了22篇报道3565例随访期为12至136个月的患者的文章。并发症发生率为17.2%(95%CI 15.9-18.5)。硬结是最常见的并发症(33.3%,95%CI 20.4-46.3),其次是持续性疼痛(25%,95%CI 0.5-49.5)和血肿(16.4%,95%CI 14.5-18.4)。乳房X线照片显示微钙化(9.0%,95%CI 6.4-11.5)和大块钙化(7.0%,95%CI 3.8-10.2)。乳房平均大小保持率为62.4%(范围44.7-82.6%),患者满意率为92%,外科医生满意率为89%。

综上所述,本综述发现,AFG是一种很有前途的方法,可以分别在8项和6项研究中实现自体美容丰胸,体积保持率和满意度均令人满意。并发症和放射学发现与植入物增强后的相似。未来的研究应侧重于癌症的发生和发现,以进一步证实AFG的安全性。此外,应研究移植方法和使用辅助程序来确定导致体积保持方面更好结果的因素。最后,需要客观的问卷来表示患者的满意度。

原始出处:

Groen JW, Negenborn VL, et al., Autologous Fat Grafting in Cosmetic Breast Augmentation: A Systematic Review on RadiologicalSafety, Complications, Volume Retention, and Patient/Surgeon Satisfaction. Aesthet Surg J. 2016 Oct;36(9):993-1007. doi: 10.1093/asj/sjw105. Epub 2016 Jun 21.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688868, encodeId=391d1688868b0, content=<a href='/topic/show?id=1e74e993465' target=_blank style='color:#2F92EE;'>#美容#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79934, encryptionId=1e74e993465, topicName=美容)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23128667605, createdName=12498adam49暂无昵称, createdTime=Sun Mar 24 03:32:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051319, encodeId=1d0f20513192c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Aug 02 23:32:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544077, encodeId=91bb15440e77a, content=<a href='/topic/show?id=610d266582b' target=_blank style='color:#2F92EE;'>#体脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26658, encryptionId=610d266582b, topicName=体脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e74a13632472, createdName=ms4964546379600229, createdTime=Sun Jan 13 16:32:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357904, encodeId=636e35e9042f, content=不清楚, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Jan 12 09:11:58 CST 2019, time=2019-01-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688868, encodeId=391d1688868b0, content=<a href='/topic/show?id=1e74e993465' target=_blank style='color:#2F92EE;'>#美容#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79934, encryptionId=1e74e993465, topicName=美容)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23128667605, createdName=12498adam49暂无昵称, createdTime=Sun Mar 24 03:32:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051319, encodeId=1d0f20513192c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Aug 02 23:32:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544077, encodeId=91bb15440e77a, content=<a href='/topic/show?id=610d266582b' target=_blank style='color:#2F92EE;'>#体脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26658, encryptionId=610d266582b, topicName=体脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e74a13632472, createdName=ms4964546379600229, createdTime=Sun Jan 13 16:32:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357904, encodeId=636e35e9042f, content=不清楚, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Jan 12 09:11:58 CST 2019, time=2019-01-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1688868, encodeId=391d1688868b0, content=<a href='/topic/show?id=1e74e993465' target=_blank style='color:#2F92EE;'>#美容#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79934, encryptionId=1e74e993465, topicName=美容)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23128667605, createdName=12498adam49暂无昵称, createdTime=Sun Mar 24 03:32:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051319, encodeId=1d0f20513192c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Aug 02 23:32:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544077, encodeId=91bb15440e77a, content=<a href='/topic/show?id=610d266582b' target=_blank style='color:#2F92EE;'>#体脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26658, encryptionId=610d266582b, topicName=体脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e74a13632472, createdName=ms4964546379600229, createdTime=Sun Jan 13 16:32:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357904, encodeId=636e35e9042f, content=不清楚, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Jan 12 09:11:58 CST 2019, time=2019-01-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688868, encodeId=391d1688868b0, content=<a href='/topic/show?id=1e74e993465' target=_blank style='color:#2F92EE;'>#美容#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79934, encryptionId=1e74e993465, topicName=美容)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23128667605, createdName=12498adam49暂无昵称, createdTime=Sun Mar 24 03:32:00 CST 2019, time=2019-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051319, encodeId=1d0f20513192c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Aug 02 23:32:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544077, encodeId=91bb15440e77a, content=<a href='/topic/show?id=610d266582b' target=_blank style='color:#2F92EE;'>#体脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26658, encryptionId=610d266582b, topicName=体脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e74a13632472, createdName=ms4964546379600229, createdTime=Sun Jan 13 16:32:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357904, encodeId=636e35e9042f, content=不清楚, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Jan 12 09:11:58 CST 2019, time=2019-01-12, status=1, ipAttribution=)]
    2019-01-12 医者仁心5538

    不清楚

    0